在偏头痛患者中,心血管风险和三类药物的使用
Ido Peles1,2, Ruth Smadar Shneyour1,2, Eran Levanon1
1Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Headache
|June 23, 2025
概括
治疗偏头痛的三类药物并没有增加心血管事件的风险,即使对于具有先前存在风险因素的患者来说也是如此. 这项研究表明,在为偏头痛管理开处子时,要仔细考虑个体患者的个人资料.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 偏头痛是一种神经血管疾病,与缺血性血管事件的更高风险有关.
- 三药是一种常见的偏头痛治疗方法,诱导血管收缩,引起了心血管风险患者的担忧.
研究的目的:
- 调查偏头痛患者的三胺使用与心血管 (CV) 事件之间的关联.
- 评估心血管风险因素的个体中平剂的安全性.
主要方法:
- 在以色列南部 (2000-2022) 进行了一项回顾性,基于人口的队列研究.
- 对26,054名偏头痛患者的电子医疗记录进行分析,评估90天内使用平坦和心血管事件.
- 对不同的时间框架和使用模式进行了敏感性分析.
主要成果:
- 48.2%的患者开始治疗三;CV风险因素在非三组中更为普遍.
- 心血管事件发生在三类药物组 (5.1%) 和非三类药物组 (4.1%) 略高.
- 多变量分析显示,三胺使用与心血管事件增加之间没有显著的关联 (aHR 0.96,95% CI 0.77-1.23).
结论:
- 在偏头痛患者中,三的使用与心血管事件的风险增加无关.
- 这一发现甚至适用于患有心血管风险因素的患者.
- 个体风险因素评估对于安全的平安药处方至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
706
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
706
Angina IV: Management
31
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
31
Imaging Studies for Cardiovascular System IV: CMRI
140
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
140
Imaging Studies for Cardiovascular System V: CT
71
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
71
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K


